Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
436.00    68.00 (18.48%)
Bid:
436.00
Ask:
437.00
Spread: 1.00 (0.229%)
Market Cap: £1.19b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Q3 Interim Management Statement

26 Jan 2017 07:00

RNS Number : 1422V
CMC Markets Plc
26 January 2017
 

26 January 2017

 

CMC MARKETS PLC

Q3 Interim Management Statement

CMC Markets plc, (LSE: CMCX, "CMC" or the "Group"), a leading global provider of online retail trading, today issues its interim management statement for the period from 1 October to 31 December 2016.

The third quarter saw some improvement in client trading activity from the previous quarter, with net operating income for the period in-line with the same period last year. Active clients continued to grow, increasing by 13% from the same period last year to 41,234, although this was offset by lower revenue per client, which was 13% below the same period last year.

The Group continues to make good progress on its strategic objectives with strong growth in active clients, extending its product offering with the launch of 'Knockouts' in Germany and Austria, further growth in its institutional offering and ongoing improvements made to digital channels.

The FCA announcement of 6 December 2016 and subsequent announcements from the German regulator, BaFin (8 December 2016) and the French regulator, AMF (10 January 2017) regarding the marketing and distribution of leveraged products are expected to impact the business when they are implemented.

At this stage, it is difficult to quantify accurately the scale of impact that the proposed regulatory changes will have on client behaviour, and therefore performance of the business, particularly as the final terms and timings of any changes are not yet finalised.

The Group has always been supportive of a clear and consistent regulatory approach, applicable to all providers, to ensure that client interests are best-served and will continue to work with the AMF, BaFin and the FCA to facilitate this. The Group believes that as one of the longest-established providers in the industry, with a focus on higher-value, experienced clients and client service, that it is well placed to deal with these changes in the competitive landscape.

As the Group enters the final quarter of the financial year, it is not possible to determine whether the recent uplift in client activity that we have seen will be sustained. However, operating costs continue to be well controlled and in-line with guidance.

CEO Peter Cruddas commented, "The regulatory changes that will be implemented later in the year will undoubtedly present the Group with some short- to medium-term challenges as clients and the industry adjust. However, as a well-capitalised and established business with 14 offices globally, a strong institutional offering and a business model that is focused on experienced clients, I believe that in the longer term the Group's competitive position will be strengthened compared to competitors whose business model is more focused towards inexperienced clients.

We are engaging fully with our regulatory bodies, and in principle, we are supportive of a clear and consistent regulatory approach that all providers have to follow to ensure client interests are best served.

We will be evolving our product offer to limit clients' downside risk with the launch of a limited risk account and continue to offer our guaranteed stop loss order.

The focus on developing our Next Generation trading platform including our mobile offering will continue as this is critical to attract and retain higher value and experienced clients.

The sector will clearly continue to be challenging while the structure and timings of the regulatory changes are confirmed. However, we believe our business is well able to adapt and we look forward to continuing our successful development within the new regulatory framework."

Forward looking statements

This trading update may include statements that are forward looking in nature. Forward looking statements involve known and unknown risks, assumptions, uncertainties and other factors which may cause the actual results, performance or achievements of the Group to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. Except as required by the Listing Rules and applicable law, the Group undertakes no obligation to update, revise or change any forward looking statements to reflect events or developments occurring after the date such statements are published.

 

Media enquiries

Camarco

Geoffrey Pelham-Lane/Ed Gascoigne-Pees/Jennifer Renwick Tel: 020 3757 4994

 

Notes to Editors CMC Markets plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX, was established in 1989 and is now one of the world's leading online financial trading businesses. The company serves retail and institutional clients through regulated offices and branches in 14 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC Markets offers an award-winning, online and mobile trading platform, enabling clients to trade over 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs") and financial spread bets (in the UK and Ireland only). Clients can also place financial binary bets through Countdowns and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBRGDBDUDBGRU
Date   Source Headline
21st Nov 20247:05 amRNSDividend Declaration
21st Nov 20247:00 amRNSInterim Results
6th Nov 20243:29 pmRNSDirector/PDMR Shareholding
9th Oct 20249:42 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTrading Statement
9th Sep 20242:50 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:13 pmRNSDirector/PDMR Shareholding
15th Aug 20243:07 pmRNSDirector/PDMR Shareholding
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
12th Aug 20249:25 amRNSDirector/PDMR Shareholding
6th Aug 20244:59 pmRNSDirector/PDMR Shareholding
25th Jul 20241:20 pmRNSResult of AGM
25th Jul 20247:00 amRNSQ1 2025 Trading Update
24th Jul 202410:42 amRNSDirector/PDMR Shareholding
10th Jul 202412:12 pmRNSDirector/PDMR Shareholding
8th Jul 20245:11 pmRNSDirector/PDMR Shareholding
24th Jun 20245:45 pmRNSNotice of AGM
20th Jun 20247:03 amRNSDirectorate Change
20th Jun 20247:03 amRNSDividend Declaration
20th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
7th Jun 202410:49 amRNSDirector/PDMR Shareholding
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM
27th Jul 20237:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.